Email This Article
Headlines & Perspectives
Elan-Wyeth Alzheimer's Data Spook Bulls
By
Adam Feuerstein
07/30/08 - 11:24 AM EDT
The stocks sell off after the presentation of underwhelming and inconclusive study results of bapineuzumab. Let's break it down.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |


Connect with TheStreet